HER2 mutation as an emerging target in advanced breast cancer.
Bon G, Di Lisa FS, Filomeno L, Arcuri T, Krasniqi E, Pizzuti L, Barba M, Messina B, Schiavoni G, Sanguineti G, Botti C, Cappelli S, Pelle F, Cavicchi F, Puccica I, Costantini M, Perracchio L, Maugeri-Saccà M, Ciliberto G, Vici P.
Bon G, et al. Among authors: di lisa fs.
Cancer Sci. 2024 May 7. doi: 10.1111/cas.16148. Online ahead of print.
Cancer Sci. 2024.
PMID: 38715247
Free article.
Review.